DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156,298,371 | -9.2% | 709,306 | -1.1% | 0.26% | -14.6% |
| Q2 2023 | $172,122,480 | -0.9% | 717,177 | +4.0% | 0.31% | 0.0% |
| Q1 2023 | $173,772,003 | -5.0% | 689,462 | +0.1% | 0.31% | -13.2% |
| Q4 2022 | $182,871,725 | +2.9% | 688,990 | +0.1% | 0.36% | -1.9% |
| Q3 2022 | $177,790,000 | -22.3% | 688,334 | -23.7% | 0.36% | +66.8% |
| Q2 2022 | $228,833,000 | -18.7% | 902,626 | -5.9% | 0.22% | +3.3% |
| Q1 2022 | $281,334,000 | -7.3% | 959,106 | +4.0% | 0.21% | -0.5% |
| Q4 2021 | $303,344,000 | +22.0% | 922,006 | +12.9% | 0.21% | +8.8% |
| Q3 2021 | $248,651,000 | +18.4% | 816,750 | +4.3% | 0.19% | +8.4% |
| Q2 2021 | $210,061,000 | +51.3% | 782,761 | +26.9% | 0.18% | +32.6% |
| Q1 2021 | $138,875,000 | +5.3% | 617,001 | +3.9% | 0.14% | +3.8% |
| Q4 2020 | $131,861,000 | +9.2% | 593,594 | +5.9% | 0.13% | -7.1% |
| Q3 2020 | $120,748,000 | +1.0% | 560,760 | -17.1% | 0.14% | +1.4% |
| Q2 2020 | $119,561,000 | +10.0% | 676,136 | -13.9% | 0.14% | -5.5% |
| Q1 2020 | $108,690,000 | -36.0% | 785,279 | -29.1% | 0.15% | -5.8% |
| Q4 2019 | $169,880,000 | -6.2% | 1,106,852 | -11.8% | 0.16% | -12.9% |
| Q3 2019 | $181,188,000 | -3.0% | 1,255,597 | -4.0% | 0.18% | +2.3% |
| Q2 2019 | $186,829,000 | +3.2% | 1,307,237 | -4.7% | 0.17% | -2.8% |
| Q1 2019 | $181,037,000 | +10.2% | 1,371,283 | -13.9% | 0.18% | -0.6% |
| Q4 2018 | $164,237,000 | -5.6% | 1,593,365 | -0.5% | 0.18% | +13.9% |
| Q3 2018 | $174,011,000 | +32.6% | 1,601,426 | +20.4% | 0.16% | +23.4% |
| Q2 2018 | $131,205,000 | -4.5% | 1,329,600 | -5.2% | 0.13% | -2.3% |
| Q1 2018 | $137,326,000 | -11.8% | 1,402,582 | -16.4% | 0.13% | +6.5% |
| Q4 2017 | $155,712,000 | +47.5% | 1,677,579 | +36.3% | 0.12% | +33.7% |
| Q3 2017 | $105,545,000 | -33.0% | 1,230,410 | -34.1% | 0.09% | -39.5% |
| Q2 2017 | $157,496,000 | -9.1% | 1,868,370 | -7.8% | 0.15% | -10.6% |
| Q1 2017 | $173,252,000 | +2.2% | 2,025,571 | -7.0% | 0.17% | +11.1% |
| Q4 2016 | $169,598,000 | +17.0% | 2,178,805 | +17.2% | 0.15% | +7.7% |
| Q3 2016 | $145,009,000 | +14.8% | 1,859,072 | +12.7% | 0.14% | +5.2% |
| Q2 2016 | $126,317,000 | -20.0% | 1,650,138 | -0.8% | 0.14% | -25.0% |
| Q1 2016 | $157,810,000 | +9.0% | 1,663,611 | +6.8% | 0.18% | +9.8% |
| Q4 2015 | $144,752,000 | -1.4% | 1,557,030 | -9.6% | 0.16% | -6.3% |
| Q3 2015 | $146,747,000 | +2.3% | 1,722,192 | +2.7% | 0.18% | +13.6% |
| Q2 2015 | $143,509,000 | +10.6% | 1,676,677 | +9.7% | 0.15% | +4.1% |
| Q1 2015 | $129,707,000 | +5.7% | 1,527,766 | +6.7% | 0.15% | +8.8% |
| Q4 2014 | $122,702,000 | +21.3% | 1,431,604 | +7.5% | 0.14% | +11.5% |
| Q3 2014 | $101,154,000 | +13.9% | 1,331,327 | +18.1% | 0.12% | +9.9% |
| Q2 2014 | $88,778,000 | -7.8% | 1,127,623 | -12.1% | 0.11% | -4.3% |
| Q1 2014 | $96,247,000 | -15.7% | 1,283,296 | -13.2% | 0.12% | -20.0% |
| Q4 2013 | $114,189,000 | -3.5% | 1,479,126 | -13.3% | 0.14% | -7.6% |
| Q3 2013 | $118,307,000 | +4.0% | 1,706,673 | -5.1% | 0.16% | -2.5% |
| Q2 2013 | $113,789,000 | – | 1,797,620 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |